Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Drug Targets|January 16, 2013
Matrix metalloproteinases as drug targets in preeclampsiaAna C T Palei, Joey P Granger, Jose E Tanus-Santos
Clinical Biochemistry|May 15, 2008
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertensionAna C T Palei, Valeria C Sandrim, Ricardo C Cavalli, et al.
Archives of Gynecology and Obstetrics|September 20, 2014
Antihypertensive therapy in preeclampsia is not modulated by VEGF polymorphismsValeria C Sandrim, Ana C T Palei, Nibia Eleuterio, et al.
Angiology|September 30, 2005
Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolismAna C T Palei, Rafael A G Zaneti, Geisa M Fortuna, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 24, 2010
Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsiaValeria C Sandrim, Ana C T Palei, Ingrid F Metzger, et al.
Molecular Human Reproduction|May 12, 2010
Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsiaValeria C Sandrim, Ana C T Palei, Jonas T Sertorio, et al.
European Journal of Clinical Pharmacology|February 10, 2011
Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markersPamela S Silva, Vanessa Fontana, Ana C T Palei, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 10, 2010
Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertensionAna C T Palei, Valeria C Sandrim, Geraldo Duarte, et al.
Hypertension (Dallas, Tex. : 1979)|June 25, 2008
Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsiaValeria C Sandrim, Ana C T Palei, Ingrid F Metzger, et al.
Clinical Biochemistry|June 21, 2011
Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activityValeria C Sandrim, Ana C T Palei, Jonas T Sertório, et al.
Pageof 3